Tanveer Ahsan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tanveer Ahsan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Ayesha Akter Jasmin
Department of Pharmacy University of Chittagong Chattogram Bangladesh
2 shared publications- Liakot Ali
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
2 shared publications - Md. Ekramul Haque Ekram
Department of Pharmacy, Faculty of Biological Sciences University of Chittagong Chittagong Bangladesh
2 shared publications - Nazratun Noor Maria
University of Sciences & Technology Chittagong (USTC)
2 shared publications - Saurav Singha
Department of Pharmacy University of Chittagong Chattogram Bangladesh
2 shared publications Umme Tahmida
Department of Pharmacy University of Chittagong Chattogram Bangladesh
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in The Scientific World Journal
- Vol. 2026 (1)
Phytochemical Profiling and Neuropharmacological Evaluation of Baccaurea motleyana Bark Extract: In Vivo and In Silico Approaches
Depression, anxiety, insomnia, and muscle spasms are globally prevalent disorders. Although Baccaurea motleyana is traditionally used in folk medicine, its neuroprotective efficacy remains unexplored. This study evaluates the anxiolytic, antidepressant, sedative, and muscle relaxant properties of its bark methanol extract (BMB‐ME) using in vivo and in silico analyses. Phytochemical analysis of BMB‐ME was assessed by gas chromatography–mass spectrometry (GC‐MS). Antidepressant activity was evaluated using the tail suspension test (TST) and forced swim test (FST), anxiolytic effects were assessed using the elevated plus maze (EPM) and hole board test (HBT), sedative effects were measured using the open field test (OFT) and hole cross test (HCT), and muscle relaxant activity was determined using the rotarod test. Moreover, molecular docking and ADMET analyses were performed. GC‐MS of BMB‐ME identified 38 compounds. It significantly reduced immobility in TST to 61.75 ± 1.87 s ( p < 0.001) and in FST to 55.52 ± 3.14 s ( p < 0.001) at 400 mg/kg. EPM results showed increased open arm time to 232.6 ± 7.24 s ( p < 0.001), whereas OFT demonstrated reduced locomotion to 45.6 ± 1.92 ( p < 0.001). Rotarod retention time decreased to 18.6 ± 0.99 s ( p < 0.001), indicating muscle relaxation. Molecular docking showed favorable binding affinities for hexadecanoic acid and gamma‐sitosterol (−8.3 to −8.1 kcal/mol), providing computational support. Overall, BMB‐ME demonstrated preliminary antidepressant‐, anxiolytic‐, sedative‐, and muscle relaxant–like effects in experimental models. Further studies are needed to isolate active compounds and clarify the underlying mechanisms.
- 1 January 2026
- Published by Wiley in The Scientific World Journal
- Vol. 2026 (1)
Open AccessPhytochemical Profiling and Neuropharmacological Evaluation of Baccaurea motleyana Bark Extract: In Vivo and In Silico Approaches
Depression, anxiety, insomnia, and muscle spasms are globally prevalent disorders. Although Baccaurea motleyana is traditionally used in folk medicine, its neuroprotective efficacy remains unexplored. This study evaluates the anxiolytic, antidepressant, sedative, and muscle relaxant properties of its bark methanol extract (BMB‐ME) using in vivo and in silico analyses. Phytochemical analysis of BMB‐ME was assessed by gas chromatography–mass spectrometry (GC‐MS). Antidepressant activity was evaluated using the tail suspension test (TST) and forced swim test (FST), anxiolytic effects were assessed using the elevated plus maze (EPM) and hole board test (HBT), sedative effects were measured using the open field test (OFT) and hole cross test (HCT), and muscle relaxant activity was determined using the rotarod test. Moreover, molecular docking and ADMET analyses were performed. GC‐MS of BMB‐ME identified 38 compounds. It significantly reduced immobility in TST to 61.75 ± 1.87 s ( p < 0.001) and in FST to 55.52 ± 3.14 s ( p < 0.001) at 400 mg/kg. EPM results showed increased open arm time to 232.6 ± 7.24 s ( p < 0.001), whereas OFT demonstrated reduced locomotion to 45.6 ± 1.92 ( p < 0.001). Rotarod retention time decreased to 18.6 ± 0.99 s ( p < 0.001), indicating muscle relaxation. Molecular docking showed favorable binding affinities for hexadecanoic acid and gamma‐sitosterol (−8.3 to −8.1 kcal/mol), providing computational support. Overall, BMB‐ME demonstrated preliminary antidepressant‐, anxiolytic‐, sedative‐, and muscle relaxant–like effects in experimental models. Further studies are needed to isolate active compounds and clarify the underlying mechanisms.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Antipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis
Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.
- 1 January 2026
- Published by Wiley in Journal of Chemistry
- Vol. 2026 (1)
Open AccessAntipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis
Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.
- Open Access
- 18 October 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (10) , e71088
Exploring the Neuropharmacological and Antipyretic Effects of Syzygium grande (Wight) Walp. Methanolic Leaf Extract: An In Vivo and Computational Study Incorporating GC – MS/MS Analysis
Syzygium grande (Wight) Walp., commonly known as the sea apple, is valued for its wide range of uses. This study aimed to investigate the pharmacological effects of a methanol extract obtained from the leaves of S. grande (MESG) in Swiss albino mice. The extract's anxiolytic potential was assessed using the elevated plus maze (EPM), hole‐board test (HBT), and light–dark test (LDT). Its antidepressant activity was evaluated through the forced swimming test (FST) and tail suspension test (TST). Sedative properties were measured using the open field test (OFT) and hole‐cross test (HCT), while antipyretic activity was determined through a yeast‐induced fever model. To identify active compounds in the extract, GC–MS/MS analysis was conducted. Additionally, computational approaches—including AutoDock Vina, Discovery Studio 2021, PASS online, and ADME/T platforms—were employed for PASS prediction analysis, ADME/T profiling, and molecular docking of various secondary metabolites. The findings indicated that MESG exhibited dose‐dependent anxiolytic, antidepressant, sedative, and antipyretic effects. A 400 mg/kg dose significantly enhanced anxiolytic activity ( p < 0.001) in all behavioral models. It also moderately reduced immobility in the FST and TST ( p < 0.01). Furthermore, MESG significantly suppressed locomotor activity in the OFT and HCT ( p < 0.001), indicating strong sedative action. The same dose effectively lowered rectal temperature in the fever model ( p < 0.05). Computational docking scores, which ranged from −2.6 to −10 kcal/mol, further supported these biological effects. In conclusion, S. grande shows considerable promise as a source of therapeutic agents for treating anxiety, depression, insomnia, and fever.
- 18 October 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (10) , e71088
Open AccessExploring the Neuropharmacological and Antipyretic Effects of Syzygium grande (Wight) Walp. Methanolic Leaf Extract: An In Vivo and Computational Study Incorporating GC – MS/MS Analysis
Syzygium grande (Wight) Walp., commonly known as the sea apple, is valued for its wide range of uses. This study aimed to investigate the pharmacological effects of a methanol extract obtained from the leaves of S. grande (MESG) in Swiss albino mice. The extract's anxiolytic potential was assessed using the elevated plus maze (EPM), hole‐board test (HBT), and light–dark test (LDT). Its antidepressant activity was evaluated through the forced swimming test (FST) and tail suspension test (TST). Sedative properties were measured using the open field test (OFT) and hole‐cross test (HCT), while antipyretic activity was determined through a yeast‐induced fever model. To identify active compounds in the extract, GC–MS/MS analysis was conducted. Additionally, computational approaches—including AutoDock Vina, Discovery Studio 2021, PASS online, and ADME/T platforms—were employed for PASS prediction analysis, ADME/T profiling, and molecular docking of various secondary metabolites. The findings indicated that MESG exhibited dose‐dependent anxiolytic, antidepressant, sedative, and antipyretic effects. A 400 mg/kg dose significantly enhanced anxiolytic activity ( p < 0.001) in all behavioral models. It also moderately reduced immobility in the FST and TST ( p < 0.01). Furthermore, MESG significantly suppressed locomotor activity in the OFT and HCT ( p < 0.001), indicating strong sedative action. The same dose effectively lowered rectal temperature in the fever model ( p < 0.05). Computational docking scores, which ranged from −2.6 to −10 kcal/mol, further supported these biological effects. In conclusion, S. grande shows considerable promise as a source of therapeutic agents for treating anxiety, depression, insomnia, and fever.
- Open Access
- 8 February 2025
- Published by Elsevier in Clinical Traditional Medicine and Pharmacology
- Vol. 6 (1)
Investigating the therapeutic potential of Baccaurea motleyana through an integrated approach utilizing in vitro, in vivo, and in silico investigations
- 8 February 2025
- Published by Elsevier in Clinical Traditional Medicine and Pharmacology
- Vol. 6 (1)
Open AccessInvestigating the therapeutic potential of Baccaurea motleyana through an integrated approach utilizing in vitro, in vivo, and in silico investigations
- Open Access
- 30 December 2024
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (1) , e4631
Investigation on Anti‐Diarrheal and Antipyretic Activities of citrus maxima Seeds in Swiss Albino Mice Model
In the Rutaceae family Citrus maxima is the biggest among all fruits, tradtionally used for several purposes due to its diverse ethnomedicinal, phytochemical, and pharmacological activities. Different portions of this plant have been used as sedatives and anti‐inflammatory medications, as well as to treat coughs, fevers, asthma, diarrhea, ulcers, and diabetes. There is a scientific potential for the methanolic seed extract to contain bioactive compounds, similar to those found in other parts of the plant. The extract derived from the seeds has already demonstrated potential biological activity. Moreover, there weren't many in vivo and in vitro research works on these plants' seeds. Therefore, the current research work was undertaken to analyze anti‐diarrheal and antipyretic potentials of the methanolic extract of Citrus maxima seeds (MCM). To evaluate MCM's effectiveness in treating diarrhea, castor oil‐induced diarrhea model was utilized as an evaluating method. The antipyretic effect in mice was measured using brewer's yeast induced pyrexia model. The MCM at 200 and 400 mg/kg doses markedly reduced hyperpyrexia, induced by yeast. The effect remained persistent up to 4th hour after administration. In the castor oil induced diarrhea model, the methanolic seed extract showed high level of dose dependent inhibition of diarrhea for 4 h following castor oil administration. Further investigation is necessary to elucidate and clarify the specific causative agents responsible for the dose‐dependent effects observed. The findings of the present study suggest that MCM seed extract may represent a promising alternative for the development of innovative anti‐diarrheal and anti‐pyretic compounds.
- 30 December 2024
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (1) , e4631
Open AccessInvestigation on Anti‐Diarrheal and Antipyretic Activities of citrus maxima Seeds in Swiss Albino Mice Model
In the Rutaceae family Citrus maxima is the biggest among all fruits, tradtionally used for several purposes due to its diverse ethnomedicinal, phytochemical, and pharmacological activities. Different portions of this plant have been used as sedatives and anti‐inflammatory medications, as well as to treat coughs, fevers, asthma, diarrhea, ulcers, and diabetes. There is a scientific potential for the methanolic seed extract to contain bioactive compounds, similar to those found in other parts of the plant. The extract derived from the seeds has already demonstrated potential biological activity. Moreover, there weren't many in vivo and in vitro research works on these plants' seeds. Therefore, the current research work was undertaken to analyze anti‐diarrheal and antipyretic potentials of the methanolic extract of Citrus maxima seeds (MCM). To evaluate MCM's effectiveness in treating diarrhea, castor oil‐induced diarrhea model was utilized as an evaluating method. The antipyretic effect in mice was measured using brewer's yeast induced pyrexia model. The MCM at 200 and 400 mg/kg doses markedly reduced hyperpyrexia, induced by yeast. The effect remained persistent up to 4th hour after administration. In the castor oil induced diarrhea model, the methanolic seed extract showed high level of dose dependent inhibition of diarrhea for 4 h following castor oil administration. Further investigation is necessary to elucidate and clarify the specific causative agents responsible for the dose‐dependent effects observed. The findings of the present study suggest that MCM seed extract may represent a promising alternative for the development of innovative anti‐diarrheal and anti‐pyretic compounds.
- Open Access
- 3 February 2023
- Published by Springer Nature in Clinical Phytoscience
- Vol. 9 (1) , 1-9
Anxiolytic, analgesic and anti-inflammatory effects of Citrus maxima (Burm.) Merr. Seed extract in Swiss albino mice model
Background: Citrus maxima (Burm.) Merr. is traditionally used for its diverse pharmacological properties. Therefore, there remains a possibility that the seed extract may contain some bioactive compounds. The present study was carried out to evaluate the anxiolytic, analgesic, and anti-inflammatory effects of methanolic seed extract of Citrus maxima (MECM). Method: The effect of MECM on the rodent central nervous system was evaluated using the hole-board and elevated plus-maze method. Analgesic effect was measured with the acetic acid-induced writhing and formalin-induced paw licking method. The anti-inflammatory effect was examined using a formalin and carrageenan-induced mice paw edema model. Results: The MECM at doses of 200 mg/kg and 400 mg/kg significantly (p < 0.01) increased the number of head dipping in the hole-board test. Additionally, the test subjects entered into the open arm and spent more time in it at an increased rate (p < 0.01) in the elevated plus-maze test. In the acetic acid-induced writhing method, the extract showed high potential (p < 0.001) as an analgesic agent. In the case of formalin-induced pain assessment, MECM demonstrated a significant effect (p < 0.01) at the early phase as a centrally acting anti-nociceptive agent and very high potential (p < 0.001) to reduce pain during the late phase as a peripherally acting analgesic. The extract also showed potency (p < 0.01) as an anti-inflammatory agent in formalin and carrageenan-induced mice paw edema test. Conclusion: The findings of the current study indicate that MECM can be a promising new candidate for searching novel anxiolytic, analgesic, and anti-inflammatory compounds through further investigation.
- 3 February 2023
- Published by Springer Nature in Clinical Phytoscience
- Vol. 9 (1) , 1-9
Open AccessAnxiolytic, analgesic and anti-inflammatory effects of Citrus maxima (Burm.) Merr. Seed extract in Swiss albino mice model
Background: Citrus maxima (Burm.) Merr. is traditionally used for its diverse pharmacological properties. Therefore, there remains a possibility that the seed extract may contain some bioactive compounds. The present study was carried out to evaluate the anxiolytic, analgesic, and anti-inflammatory effects of methanolic seed extract of Citrus maxima (MECM). Method: The effect of MECM on the rodent central nervous system was evaluated using the hole-board and elevated plus-maze method. Analgesic effect was measured with the acetic acid-induced writhing and formalin-induced paw licking method. The anti-inflammatory effect was examined using a formalin and carrageenan-induced mice paw edema model. Results: The MECM at doses of 200 mg/kg and 400 mg/kg significantly (p < 0.01) increased the number of head dipping in the hole-board test. Additionally, the test subjects entered into the open arm and spent more time in it at an increased rate (p < 0.01) in the elevated plus-maze test. In the acetic acid-induced writhing method, the extract showed high potential (p < 0.001) as an analgesic agent. In the case of formalin-induced pain assessment, MECM demonstrated a significant effect (p < 0.01) at the early phase as a centrally acting anti-nociceptive agent and very high potential (p < 0.001) to reduce pain during the late phase as a peripherally acting analgesic. The extract also showed potency (p < 0.01) as an anti-inflammatory agent in formalin and carrageenan-induced mice paw edema test. Conclusion: The findings of the current study indicate that MECM can be a promising new candidate for searching novel anxiolytic, analgesic, and anti-inflammatory compounds through further investigation.